Important Safety Alerts

Medical device manufacturer, Biomerieux, has issued a medical device safety alert concerning its VIDAS FT4 [Reference Number: 30459; Lot Number (Expiry Date): 1007146010 (13 Feb 2020), 1006987180 (29 Nov 2019), 1007008470 (9 Dec 2019), 1006896240 (20 Oct 2019), 1006878320 (14 Oct 2019), 1006942720 (9 Nov 2019)].

The manufacturer received complaints about underestimated FT4 results obtained on the affected products which were not in line with TSH results or non-consistent with FT4 results obtained using other commercially available tests. An investigation carried out on all lots available on the market and to date the manufacturer observed the following:

1. A drift of FT4 values during the shelf life of the product VIDAS FT4 lot1007146010/ lot1006987180/ lot1007008470 /lot1006896240.
2. No abnormality for all the other lots including VIDAS FT4 lots 1006878320 / 1006942720 although an higher rate of complaints was recorded.

The analysis of the batch history records for concerned products shows no anomaly during the manufacturing, control and packaging processes. To date the investigation and root cause analysis are still ongoing.

The risk caused by the observed drift is an underestimated FT4 result. As per investigation data, underestimated values can be obtained for samples with low FT4 values. Preliminary investigation data showed that there is no impact on results for samples with high FT4 values (i.e. above 19.4 pmol/l.) As indicated in the instructions for use, VIDAS FT4 assay results should be interpreted as part of a complete clinical evaluation and thyroid function assessment, including at least TSH determination.

Users are advised to do the following actions:

• Stop using and destroy any stock of the affected products and remaining in the inventory.
• The manufacturer requests also to stop using and to destroy any stock of VIDAS FT4 lots 1006878320 and 1006942720 as a precautionary measure due to the number of complaints received, although, to date, no issue was identified for these two lots.
• Discuss any concerns users may have regarding previously reported patients results obtained with lot1007146010/ lot1006987180/ lot1007008470/ lot1006896240 of VIDAS FT4 (Ref. 30459) with the Laboratory Medical Director to determine the appropriate course of action. Results should be reviewed and interpreted in the overall clinical context.

If you are in possession of the products, please contact your supplier for necessary actions.

Posted on 9 August 2019